Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database. [PDF]
Kang WH +8 more
europepmc +1 more source
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy. [PDF]
Lee SW +7 more
europepmc +1 more source
Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II. [PDF]
Yoshikawa T +8 more
europepmc +1 more source
Prediction of microvascular invasion and post-resection prognosis using ADV, AFP-PIVKA-II, and MoRAL scores in hepatocellular carcinoma patients: an international multicenter cohort study with 9,061 patients. [PDF]
Choi M +5 more
europepmc +1 more source
The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinoma. [PDF]
Tran VT +17 more
europepmc +1 more source
Lack of blood may drive liver neoplasm: a case of an intrahepatic portosystemic venous shunt and liver focal nodular hyperplasia with elevation of serum PIVKA-II level. [PDF]
Mao Y, Zheng H, Wan X, Xu Y, Du S.
europepmc +1 more source
Characterization of PIVKA-II Molecular Forms via Size Exclusion Chromatography and Hydrophobic Interaction Chromatography in HCC Patients. [PDF]
Kitamura Y, Aoyagi K.
europepmc +1 more source
Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort. [PDF]
Pham TTT, Ho DT, Nguyen TB, Phan HT.
europepmc +1 more source
Diagnostic Performance Comparison of AFP, PIVKA-II, GALAD Model, and ASAP Model Across Two Chemiluminescence Immunoassay Platforms for Hepatocellular Carcinoma. [PDF]
Huang Y +6 more
europepmc +1 more source
[A case of PIVKA-II and AFP producing gastric carcinoma].
INOUE, Toru +9 more
openaire +2 more sources

